Zobrazeno 1 - 10
of 1 042
pro vyhledávání: '"James T, Willerson"'
Autor:
Thomas J. Povsic, Ricardo Sanz‐Ruiz, Andreu M. Climent, Roberto Bolli, Doris A. Taylor, Bernard J. Gersh, Philippe Menasché, Emerson C. Perin, Giulio Pompilio, Douwe E. Atsma, Lina Badimon, Anthony N. DeMaria, Joshua M. Hare, Timothy D. Henry, Stefan Janssens, Jens Kastrup, Daniele Torella, Jay H. Traverse, James T. Willerson, Francisco Fernández‐Avilés
Publikováno v:
ESC Heart Failure, Vol 8, Iss 3, Pp 2306-2309 (2021)
Abstract The concept that cell‐based repair of myocardial injury might be possible was introduced almost two decades ago; however, the field of cardiovascular reparative medicine has been criticized as translation to clinically effective approaches
Externí odkaz:
https://doaj.org/article/aa0ac4175dff4a92ac246bdf889ab4ba
Autor:
Lourdes Chacon Alberty, Emerson C. Perin, James T. Willerson, Amir Gahremanpour, Roberto Bolli, Phillip C. Yang, Jay H. Traverse, Dejian Lai, Carl J. Pepine, Doris A. Taylor
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Cell therapy trials for heart failure (HF) have shown modest improvement; however, the mechanisms underlying improvement in some patients but not others are not well understood. Although immune cells are important in the course of HF, our understandi
Externí odkaz:
https://doaj.org/article/4d476a1f51f947dfbefc48a02577bb69
Autor:
Yuxiao Deng, Zhongwei Yang, Toya Terry, Su Pan, Darren G. Woodside, Jingxiong Wang, Kehe Ruan, James T. Willerson, Richard A. F. Dixon, Qi Liu
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-12 (2016)
Human mesenchymal stem cells (hMSC) expressing paracrine factors may enhance therapeutic benefits when transplanted. Here, the authors show that hMSCs stably expressing prostacyclin enhance host regeneration and muscle mass gain in a mouse hindlimb i
Externí odkaz:
https://doaj.org/article/6bbe1c11fdeb42e58ccce482da4df04a
Autor:
Michael P. Murphy, Ketty Bacallao, Lara M. Simpson, Aisha Khan, Joshua M. Hare, Bharath Ambale-Venkatesh, Judy Bettencourt, Dejian Lai, David P. Lee, Gregory D. Lewis, Timothy D. Henry, Bangon Longsomboon, Ray F. Ebert, Keith L. March, Mohammad R. Ostovaneh, Michelle Cohen, Ivonne Hernandez Schulman, Rachel W. Vojvodic, Carl J. Pepine, Krystalenia Valasaki, Lem Moyé, Shelly L. Sayre, Sohail Ikram, Robert D. Simari, Doris A. Taylor, Catalin Loghin, James T. Willerson, Roberto Bolli, Phillip C. Yang, David Aguilar, Barry R. Davis, Emerson C. Perin, Connor O'Brien, Adrian P. Gee, Sara Richman, Joao A.C. Lima, Raul D. Mitrani, Jay H. Traverse
Publikováno v:
European Journal of Heart Failure. 23:661-674
AIMS CONCERT-HF is an NHLBI-sponsored, double-blind, placebo-controlled, Phase II trial designed to determine whether treatment with autologous bone marrow-derived mesenchymal stromal cells (MSCs) and c-kit positive cardiac cells (CPCs), given alone
Autor:
Doris A. Taylor, Emerson C. Perin, James T. Willerson, Claudia Zierold, Micheline Resende, Marjorie Carlson, Belinda Nestor, Elizabeth Wise, Aaron Orozco, Carl J. Pepine, Timothy D. Henry, Stephen G. Ellis, David X. M. Zhao, Jay H. Traverse, John P. Cooke, Robert C. Schutt, Aruni Bhatnagar, Maria B. Grant, Dejian Lai, Brian H. Johnstone, Shelly L. Sayre, Lem Moyé, Ray F. Ebert, Roberto Bolli, Robert D. Simari
Publikováno v:
Cell Transplantation, Vol 25 (2016)
In the current study, we sought to identify bone marrow-derived mononuclear cell (BM-MNC) subpopulations associated with a combined improvement in left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV), and maximal ox
Externí odkaz:
https://doaj.org/article/4cf4483e0be94e109821143e6091df9e
Autor:
Sohail Ikram, Kathy D. Miller, Adrian P. Gee, Joshua M. Hare, Jay H. Traverse, Bharath Ambale-Venkatesh, Emerson C. Perin, Connor O'Brien, Judy Bettencourt, Ray F. Ebert, Timothy D. Henry, Roberto Bolli, Joao A.C. Lima, Carl J. Pepine, Dejian Lai, David P. Lee, Phillip C. Yang, Shelly L. Sayre, Keith L. March, Michelle Cohen, Lara M. Simpson, Sara Richman, Michael P. Murphy, Doris A. Taylor, Mohammad R. Ostovaneh, Lem Moyé, Raul D. Mitrani, Rachel W. Vojvodic, Robert D. Simari, Catalin Loghin, Jean-Bernard Durand, James T. Willerson, David Aguilar, Barry R. Davis
Publikováno v:
JACC: CardioOncology. 2:581-595
Background Anthracycline-induced cardiomyopathy (AIC) may be irreversible with a poor prognosis, disproportionately affecting women and young adults. Administration of allogeneic bone marr...
Publikováno v:
Tex Heart Inst J
In a previous cross-sectional screening study of 5,169 middle and high school students (mean age, 13.1 ± 1.78 yr) in which we estimated the prevalence of high-risk cardiovascular conditions associated with sudden cardiac death, we incidentally detec
Autor:
James T. Willerson, Emerson C. Perin, Jay H. Traverse, Phillip C. Yang, Doris A. Taylor, Carl J. Pepine, Roberto Bolli, Lourdes Chacon Alberty, Amir Gahremanpour, Dejian Lai
Publikováno v:
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Cell therapy trials for heart failure (HF) have shown modest improvement; however, the mechanisms underlying improvement in some patients but not others are not well understood. Although immune cells are important in the course of HF, our understandi
Autor:
Ke Li, Leonardo Wagner Florencio, Emerson C. Perin, Francisco Grisanti, James T. Willerson, Li Tang, Yidan Wang, John Leach, Sui Zhang, Todd Heallen, James F. Martin, Shijie Liu
Publikováno v:
Sci Transl Med
Human heart failure, a leading cause of death worldwide, is a prominent example of a chronic disease that may result from poor cell renewal. The Hippo signaling pathway is an inhibitory kinase cascade that represses adult heart muscle cell (cardiomyo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75f631938d37b963d1f7e10541916324
https://europepmc.org/articles/PMC9476348/
https://europepmc.org/articles/PMC9476348/
Autor:
James T. Willerson, Toban Dvoretzky
Publikováno v:
Texas Heart Institute Journal. 46:83-86